Resection of phaeochromocytoma extending into the right atrium in a patient with multiple endocrine neoplasia type 2A.

PubWeight™: 1.42‹?› | Rank: Top 5%

🔗 View Article (PMID 15687519)

Published in Hong Kong Med J on February 01, 2005

Authors

C F Ku1, C Y Lo, W F Chan, S W Chiu, S T Fan, K S L Lam

Author Affiliations

1: Department of Surgery, University of Hong Kong, Queen Mary Hospital, Pokfulam Road, Hong Kong.

Articles citing this

More on phaeochromocytoma. Hong Kong Med J (2005) 0.75

Bilateral Pheochromocytomas in MEN2A Syndrome: A Two-Institution Experience. World J Surg (2015) 0.75

Articles by these authors

Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg (2000) 4.44

Endoscopic biliary drainage for severe acute cholangitis. N Engl J Med (1992) 4.29

Prospective randomized study of early versus delayed laparoscopic cholecystectomy for acute cholecystitis. Ann Surg (1998) 3.43

Improving survival results after resection of hepatocellular carcinoma: a prospective study of 377 patients over 10 years. Ann Surg (2001) 3.25

Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma. Cancer (2000) 3.23

Intrahepatic recurrence after curative resection of hepatocellular carcinoma: long-term results of treatment and prognostic factors. Ann Surg (1999) 3.05

Hepatic resection for hepatocellular carcinoma. An audit of 343 patients. Ann Surg (1995) 3.04

Early versus delayed-interval laparoscopic cholecystectomy for acute cholecystitis: a metaanalysis. Surg Endosc (2005) 3.03

Anterior approach for difficult major right hepatectomy. World J Surg (1996) 2.94

Prospective evaluation of Pringle maneuver in hepatectomy for liver tumors by a randomized study. Ann Surg (1997) 2.83

Lipopolysaccharide induction of the tumor necrosis factor-alpha promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-kappaB transcription factors. J Biol Chem (1997) 2.73

Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management. Am J Gastroenterol (1999) 2.47

Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg (1997) 2.44

Aqueous humor in glaucomatous eyes contains an increased level of TGF-beta 2. Exp Eye Res (1994) 2.40

Metastatic tumors of the thyroid gland: a study of 79 cases in Chinese patients. Arch Pathol Lab Med (1998) 2.40

Association of genetic variation in FTO with risk of obesity and type 2 diabetes with data from 96,551 East and South Asians. Diabetologia (2011) 2.37

Preoperative endoscopic drainage for malignant obstructive jaundice. Br J Surg (1994) 2.22

beta-Catenin mutation and overexpression in hepatocellular carcinoma: clinicopathologic and prognostic significance. Cancer (2001) 2.17

Clinical implications of circulating angiogenic factors in cancer patients. J Clin Oncol (2001) 2.15

Treatment of fungal peritonitis complicating continuous ambulatory peritoneal dialysis with oral fluconazole: a series of 21 patients. Nephrol Dial Transplant (1994) 2.11

Factors predictive of 5-year survival after transarterial chemoembolization for inoperable hepatocellular carcinoma. Br J Surg (2003) 2.10

Stochastic theory of ion movement in channels with single-ion occupancy. Application to sodium permeation of gramicidin channels. Biophys J (1987) 2.04

Mechanism of protective immunity against influenza virus infection in mice without antibodies. J Immunol (1998) 2.03

The clinical significance of routine histopathologic study of the resected appendix and safety of appendiceal inversion. Surg Gynecol Obstet (1986) 2.02

Significance of resection margin in hepatectomy for hepatocellular carcinoma: A critical reappraisal. Ann Surg (2000) 2.01

Pancreatic solid-cystic-papillary tumor: clinicopathologic features in eight patients from Hong Kong and review of the literature. World J Surg (1999) 1.98

Mechanisms of heterosubtypic immunity to lethal influenza A virus infection in fully immunocompetent, T cell-depleted, beta2-microglobulin-deficient, and J chain-deficient mice. J Immunol (1997) 1.95

Management of spontaneous rupture of hepatocellular carcinoma: single-center experience. J Clin Oncol (2001) 1.93

Early versus delayed laparoscopic cholecystectomy for treatment of acute cholecystitis. Ann Surg (1996) 1.92

The bacteriology and septic complication of patients with appendicitis. Ann Surg (1984) 1.89

Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or gamma delta T cells. J Immunol (2001) 1.86

Evaluation of preoperative hepatic function in patients with hepatocellular carcinoma undergoing hepatectomy. Br J Surg (1997) 1.86

Anterior approach for major right hepatic resection for large hepatocellular carcinoma. Ann Surg (2000) 1.83

Identification and characterization of a novel human aldose reductase-like gene. J Biol Chem (1998) 1.82

Adrenal lipomatous tumours: a 30 year clinicopathological experience at a single institution. J Clin Pathol (2001) 1.75

Treatment of advanced hepatocellular carcinoma with tamoxifen and the correlation with expression of hormone receptors: a prospective randomized study. Am J Gastroenterol (2000) 1.73

Distinct genotypic distributions of cytomegalovirus (CMV) envelope glycoprotein in bone marrow and renal transplant recipients with CMV disease. Clin Diagn Lab Immunol (1997) 1.71

Spontaneous rupture of hepatocellular carcinoma. Br J Surg (1996) 1.68

Hypoadiponectinemia is associated with impaired endothelium-dependent vasodilation. J Clin Endocrinol Metab (2004) 1.66

Biliary complications after hepatic resection: risk factors, management, and outcome. Arch Surg (1998) 1.63

Bleeding peptic ulcer: a prospective evaluation of risk factors for rebleeding and mortality. World J Surg (1990) 1.63

Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence. J Surg Oncol (2000) 1.62

Serum adipocyte fatty acid-binding protein levels were independently associated with carotid atherosclerosis. Arterioscler Thromb Vasc Biol (2007) 1.62

Serum adipocyte fatty acid-binding protein associated with ischemic stroke and early death. Neurology (2011) 1.60

Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg (2007) 1.56

Sphingomyelin-cholesterol domains in phospholipid membranes: atomistic simulation. Biophys J (2004) 1.55

Primary squamous cell carcinoma of the thyroid gland: an entity with aggressive clinical behaviour and distinctive cytokeratin expression profiles. Histopathology (2001) 1.55

Postoperative adjuvant chemotherapy after curative resection of hepatocellular carcinoma: a randomized controlled trial. Arch Surg (1998) 1.54

Internet addiction in Chinese adolescents in Hong Kong: assessment, profiles, and psychosocial correlates. ScientificWorldJournal (2008) 1.54

Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective study. Ann Surg (2001) 1.52

Surgical implications of underestimation of adrenal tumour size by computed tomography. Br J Surg (1999) 1.50

A critical examination of adrenal tuberculosis and a 28-year autopsy experience of active tuberculosis. Clin Endocrinol (Oxf) (2001) 1.49

Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma. Br J Surg (1998) 1.42

Desmopressin does not decrease blood loss and transfusion requirements in patients undergoing hepatectomy. Can J Anaesth (2003) 1.42

Clinicopathologic features of long-term survivors and disease-free survivors after resection of hepatocellular carcinoma: a study of a prospective cohort. J Clin Oncol (2001) 1.41

Repair of ruptured sinus of valsalva aneurysm: determinants of long-term survival. Ann Thorac Surg (1998) 1.41

AXL receptor kinase is a mediator of YAP-dependent oncogenic functions in hepatocellular carcinoma. Oncogene (2010) 1.40

Microvessel density, vascular endothelial growth factor and its receptors Flt-1 and Flk-1/KDR in hepatocellular carcinoma. Am J Clin Pathol (2001) 1.39

Minimum graft size for successful living donor liver transplantation. Transplantation (1999) 1.39

Pancreatic pleural effusion: an indication for emergency distal pancreatectomy and Roux-en-Y pancreatico-jejunostomy. J Pediatr Surg (1994) 1.38

Early decision for conversion of laparoscopic to open cholecystectomy for treatment of acute cholecystitis. Am J Surg (1997) 1.36

Vaccination with DNA encoding internal proteins of influenza virus does not require CD8(+) cytotoxic T lymphocytes: either CD4(+) or CD8(+) T cells can promote survival and recovery after challenge. Int Immunol (2000) 1.35

Resection for extrahepatic recurrence of hepatocellular carcinoma. Br J Surg (1994) 1.34

Prognostic significance of pathologic features of hepatocellular carcinoma. A multivariate analysis of 278 patients. Cancer (1995) 1.33

Atorvastatin lowers C-reactive protein and improves endothelium-dependent vasodilation in type 2 diabetes mellitus. J Clin Endocrinol Metab (2002) 1.32

Long-term results of resection for large hepatocellular carcinoma: a multivariate analysis of clinicopathological features. Hepatology (1990) 1.31

Spontaneous rupture of hepatocellular carcinoma and vascular injury. Arch Surg (2001) 1.30

A randomised controlled trial of nasal continuous positive airway pressure on insulin sensitivity in obstructive sleep apnoea. Eur Respir J (2009) 1.28

Factors affecting conversion of laparoscopic cholecystectomy to open surgery. Arch Surg (1996) 1.28

Pyogenic liver abscess. An audit of experience over the past decade. Arch Surg (1996) 1.27

Somatostatin in the treatment of acute pancreatitis: a prospective randomised controlled trial. Gut (1989) 1.26

Tumor encapsulation in hepatocellular carcinoma. A pathologic study of 189 cases. Cancer (1992) 1.25

Long term prognosis after hepatectomy for hepatocellular carcinoma: a survival analysis of 204 consecutive patients. Cancer (1998) 1.24

Long-term prognosis after resection of hepatocellular carcinoma associated with hepatitis B-related cirrhosis. J Clin Oncol (2000) 1.24

Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma. Cancer (1994) 1.23

Biliary complications during liver resection. World J Surg (2001) 1.23

Major hepatectomy for hepatocellular carcinoma in patients with an unsatisfactory indocyanine green clearance test. Br J Surg (1999) 1.22

Pancreatic endocrine tumour: a 22-year clinico-pathological experience with morphological, immunohistochemical observation and a review of the literature. Eur J Surg Oncol (1997) 1.22

Ruptured hepatocellular carcinoma as a complication of transarterial oily chemoembolization. Br J Surg (1998) 1.22

Inhibition of hydroxymethylglutaryl-coenzyme A synthase by L-659,699. Proc Natl Acad Sci U S A (1987) 1.21

Acute torsion of the gall bladder in the aged: a re-emphasis on clinical diagnosis. Aust N Z J Surg (1982) 1.21

Endoscopic retrograde cholangiopancreatography and endoscopic endoprosthesis insertion in patients with Klatskin tumors. Arch Surg (1998) 1.21

Laparoscopy and laparoscopic ultrasonography avoid exploratory laparotomy in patients with hepatocellular carcinoma. Ann Surg (1998) 1.20

A non-fatal impalement injury of the thorax. J R Coll Surg Edinb (1998) 1.19

Prophylactic effect of somatostatin on post-ERCP pancreatitis: a randomized controlled trial. Gastrointest Endosc (1999) 1.19

Rapid cytomegalovirus pp65 antigenemia assay by direct erythrocyte lysis and immunofluorescence staining. J Clin Microbiol (1998) 1.18

Cross-talk between adipose tissue and vasculature: role of adiponectin. Acta Physiol (Oxf) (2010) 1.18

Liver transplantation in rats using small-for-size grafts: a study of hemodynamic and morphological changes. Arch Surg (2001) 1.15

Correlation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinoma. Am J Surg (2001) 1.15

Hepatic potential of bone marrow stromal cells: development of in vitro co-culture and intra-portal transplantation models. J Immunol Methods (2005) 1.14

Randomized, prospective, and double-blind trial of new beta-lactams in the treatment of appendicitis. Antimicrob Agents Chemother (1985) 1.13

Impact of postoperative complications on long-term outcome of curative resection for hepatocellular carcinoma. Br J Surg (2009) 1.13

Randomised controlled trial of qigong in the treatment of mild essential hypertension. J Hum Hypertens (2005) 1.13

Emergency surgery for severe acute cholangitis. The high-risk patients. Ann Surg (1990) 1.12

Emergency surgery for colonic diverticulitis: differences between right-sided and left-sided lesions. Int J Colorectal Dis (2001) 1.12

Spontaneous ruptured hepatocellular carcinoma. An appraisal of surgical treatment. Ann Surg (1989) 1.11

Tolerance of the liver to intermittent pringle maneuver in hepatectomy for liver tumors. Arch Surg (1999) 1.11

A multicentric study of netilmicin once daily versus thrice daily in patients with appendicitis and other intra-abdominal infections. J Antimicrob Chemother (1989) 1.11

Intrahepatic cholangiocarcinoma. World J Surg (1997) 1.11